£595.00

The 2016-2021 Outlook for Narcolepsy Therapeutics in Japan

Price data last checked 18 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£595 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 73 days · 73 data points (no recent data)

Historical
Generating forecast…
£595.00 £565.25 £577.15 £589.05 £600.95 £612.85 £624.75 10 June 2026 28 June 2026 16 July 2026 03 August 2026 21 August 2026

Price Distribution

Price distribution over 73 days • 1 price levels

Days at Price
73 days 0 18 37 55 73 £595 Days at Price

Price Analysis

Most common price: £595 (73 days, 100.0%)

Price range: £595 - £595

Price levels: 1 different prices over 73 days

Description

This econometric study covers the latent demand outlook for narcolepsy therapeutics across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,000 cities in Japan. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for narcolepsy therapeutics. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the cities in Japan). This study gives, however, my estimates for the latent demand, or the P.I.E., for narcolepsy therapeutics in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
22 September 2015
Listed Since
16 December 2016

Similar Products You Might Like

The 2023-2028 Outlook for Narcolepsy Drugs in India
99% match

The 2023-2028 Outlook for Narcolepsy Drugs in India

£515.00 21 Aug 2026
The 2026-2031 World Outlook for Narcolepsy Drugs
99% match

The 2026-2031 World Outlook for Narcolepsy Drugs

£885.00 21 Aug 2026
The 2016 Report on Narcolepsy Therapeutics: World Market Segmentation by City
99% match

The 2016 Report on Narcolepsy Therapeutics: World Market Segmentation by City

£995.00 22 Aug 2026
The 2026-2031 World Outlook for Therapeutics for Narcolepsy with Cataplexy
99% match

The 2026-2031 World Outlook for Therapeutics for Narcolepsy with Cataplexy

£885.00 22 Aug 2026
The 2023-2028 Outlook for Narcolepsy Drugs in China
98% match

The 2023-2028 Outlook for Narcolepsy Drugs in China

£495.00 21 Aug 2026
The 2023-2028 Outlook for Therapeutics for Narcolepsy with Cataplexy in Japan
98% match

The 2023-2028 Outlook for Therapeutics for Narcolepsy with Cataplexy in Japan

£495.00 22 Aug 2026
The 2023-2028 Outlook for Therapeutics for Narcolepsy with Cataplexy for US Zip Codes
98% match

The 2023-2028 Outlook for Therapeutics for Narcolepsy with Cataplexy for US Zip Codes

£490.00 24 Aug 2026
The 2023-2028 Outlook for Narcolepsy Drugs for US Zip Codes
98% match

The 2023-2028 Outlook for Narcolepsy Drugs for US Zip Codes

£490.00 20 Aug 2026
The 2023-2028 Outlook for Insomnia Therapeutics in the United States
97% match

The 2023-2028 Outlook for Insomnia Therapeutics in the United States

£520.00 20 Aug 2026
The 2023-2028 Outlook for Insomnia Drugs in the United States
96% match

The 2023-2028 Outlook for Insomnia Drugs in the United States

£520.00 22 Aug 2026
The 2023-2028 Outlook for Insomnia Therapeutics in India
96% match

The 2023-2028 Outlook for Insomnia Therapeutics in India

£515.00 22 Aug 2026
The 2023-2028 Outlook for Insomnia Drugs in India
96% match

The 2023-2028 Outlook for Insomnia Drugs in India

£515.00 21 Aug 2026
The 2023-2028 Outlook for Sleep Aids in the United States
96% match

The 2023-2028 Outlook for Sleep Aids in the United States

£520.00 27 Aug 2026
The 2023-2028 Outlook for Prescription Sleep-Aid Insomnia Drugs in the United States
96% match

The 2023-2028 Outlook for Prescription Sleep-Aid Insomnia Drugs in the United States

£520.00 21 Aug 2026
The 2016-2021 Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs in Japan
96% match

The 2016-2021 Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs in Japan

£595.00 26 Aug 2026
The 2023-2028 Outlook for Prescription Sleep-Aid Insomnia Drugs in India
96% match

The 2023-2028 Outlook for Prescription Sleep-Aid Insomnia Drugs in India

£515.00 25 Aug 2026
The 2016-2021 Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs in the United States
96% match

The 2016-2021 Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs in the United States

£595.00 25 Aug 2026
The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in the United States
96% match

The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in the United States

£595.00 10 Jul 2026
The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in Japan
96% match

The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in Japan

£595.00 05 Sep 2026
The 2016-2021 Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs in Greater China
96% match

The 2016-2021 Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs in Greater China

£595.00 22 Aug 2026
The 2016-2021 Outlook for Pharmaceutical Preparations for Human Use Acting on the Central Nervous System and the Sense Organs in the United States
96% match

The 2016-2021 Outlook for Pharmaceutical Preparations for Human Use Acting on the Central Nervous System and the Sense Organs in the United States

£595.00 25 Aug 2026